Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(14/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(14/week)
News
United States
(565/week)
Manufacturing
(380/week)
Energy
(296/week)
Technology
(385/week)
Environment
(222/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Caphosol
Feb 03, 2020
Soligenix Announces Japanese Patent Allowance for Use of Dusquetide in Oral Mucositis
Aug 28, 2019
Soligenix Announces Positive Recommendation by Independent Data Monitoring Committee on its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer
Aug 15, 2019
Soligenix Announces $150,000 NIH Small Business Innovation Research Award Supporting Evaluation of SGX942 in Pediatric Indications
Apr 18, 2019
Soligenix Achieves Significant Enrollment Milestone for its Pivotal Phase 3 Clinical Trial of SGX942 in the Treatment of Oral Mucositis in Head and Neck Cancer
Apr 09, 2019
Soligenix and the European Medicines Agency Pediatric Committee Reach Agreement on the Pediatric Investigation Plan for SGX942
Apr 04, 2019
Soligenix Receives US Patent for Dusquetide Related Analogs
Mar 18, 2019
Soligenix to Present at National Institutes of Health - Commercialization Accelerator Program "FeedForward Session" in Washington, DC
Jan 23, 2019
Soligenix Receives European Patent for Dusquetide and Related Innate Defense Regulator Analogs
Sep 13, 2018
NIH selects Soligenix's SGX942 in the Treatment of Oral Mucositis for the Commercialization Accelerator Program
Jan 02, 2018
Soligenix Announces US Patent Issuance for Use of Dusquetide in Oral Mucositis
Oct 05, 2017
Dusquetide Technology Platform to be Presented at the 2nd World Congress and Expo on Immunology
Sep 20, 2017
Soligenix Announces $1.5 Million NIDCR SBIR Grant Award Supporting the Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer
Aug 11, 2017
Soligenix Announces Recent Accomplishments And Second Quarter 2017 Financial Results
Aug 02, 2017
Enzychem Lifesciences's investigational new drug application (IND) for chemoradiation induced oral mucositis had been granted by the FDA
Jul 27, 2017
Soligenix Initiates Pivotal Phase 3 Clinical Trial of SGX942 (Dusquetide) for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
Jun 19, 2017
Complete Efficacy and Long-Term Follow-Up Safety Results from SGX942 Phase 2 Oral Mucositis Clinical Trial to be Presented at the 2017 Multinational Association for Supportive Care in Cancer Conference
Latest News
Apr 23, 2024
Shippeo Spring Platform Release Reveals All-new Parcel Tracking, Advanced Carbon Emissions Monitoring...
Apr 23, 2024
LaPhair Capital Partners Acquires Kinexx Modular Construction to Accelerate Homeownership in Urban Communities
Apr 23, 2024
Edge Impulse Brings Industrial Computer Vision Breakthroughs in Anomaly Detection to Any Edge Device for the...
Apr 23, 2024
Faraday Future Announces Werner Wilhelm as Executive Launch Director
Apr 23, 2024
Nidec Announces Financial Results for Fiscal Year Ended March 31, 2024
Apr 23, 2024
Popular uMhlanga Rocks Whalebone Pier in South Africa Gets a New Lease on Life with Penetron Technology
Apr 23, 2024
EverGen Infrastructure Reports Q4 & Year End 2023 Results
Apr 23, 2024
Grupo Aeroportuario del Pacifico Announces Results for the First Quarter of 2024
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events